KEYNOTE-427 cohort A: Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC)

Autor: J.-L. Lee, Piotr Tomczak, J.M.G. Larkin, David F. McDermott, Boris Alekseev, Frédéric Pouliot, Poul F. Geertsen, Vsevolod Matveev, Charles Schloss, R. Airatovich Gafanov, T. Alonso Gordoa, Frede Donskov, Cezary Szczylik, Paweł Wiechno, Michael B. Atkins, Jahangeer Malik, R. Kloss Silverman, Rodolfo F. Perini, Scott S. Tykodi, S.J. Shin

Publikováno v: Donskov, F, McDermott, D F, Lee, J L, Szczylik, C, Malik, J, Alekseev, B, Larkin, JMG, Matveev, VB, Airatovich, G, Tomczak, P, Tykodi, S S, Geertsen, P F, Wiechno, P, Shin, SJ, Pouliot, F, Gordoa, A, Silverman, R K, Perini, RF, Schloss, C & Atkins, M B 2018, ' KEYNOTE-427 cohort A: Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC). ', Annals of Oncology. Supplement, vol. 29, no. Supplement 8, pp. viii307 . https://doi.org/10.1093/annonc/mdy283.080

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d09bf364797e849a2d011bf3ea1fa75
https://pure.au.dk/portal/da/publications/keynote427-cohort-a-pembrolizumab-monotherapy-as-firstline-therapy-in-advanced-clear-cell-renal-cell-carcinoma-ccrcc(7654ffdb-322b-49de-b95d-e713b3af49fb).html

First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Updated follow-up for KEYNOTE-427 cohort B

Autor: T. Alonso Gordoa, Cezary Szczylik, J.-L. Lee, S.J. Shin, Charles Schloss, Scott S. Tykodi, Paweł Wiechno, Frede Donskov, Michael B. Atkins, Vsevolod Matveev, David F. McDermott, Jahangeer Malik, J.M.G. Larkin, Frédéric Pouliot, R. Kloss Silverman, Boris Alekseev, Rodolfo F. Perini, Rustem Gafanov, Poul F. Geertsen, Piotr Tomczak

Publikováno v: Annals of Oncology. 30:v381

Background KEYNOTE-427 (NCT02853344) is a single-arm, open-label, phase 2 study of pembro monotherapy in patients (pts) with advanced clear cell RCC (cohort A) and nccRCC (cohort B). Updated cohort B results with additional follow-up are presented. M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::10d2ab70920752ade71fdd6d3b69cf38
https://doi.org/10.1093/annonc/mdz249.044